Display Settings:

Format

Send to:

Choose Destination

    Eur J Biochem. 1995 Mar 15;228(3):931-4.

    Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients.

    Khamlichi S, Bailly P, Blanchard D, Goossens D, Cartron JP, Bertrand O.

    INSERM U76, Institut National de la Transfusion Sanguine, Paris, France.

    A 37-kDa protein was immunopurified from human erythrocytes as a complex with a monoclonal antibody directed against the Kell blood group protein of 93 kDa. A rabbit antibody raised against the purified complex reacted on a Western blot with the 93-kDa and 37-kDa proteins and was able to immunoprecipitate the 37-kDa component from K0 erythrocytes which express large amount of the Kx antigen, but not from erythrocytes of patients suffering from McLeod syndrome, a X-linked disorder in which the Kx antigen is lacking. Additional studies have shown that the 37-kDa protein is not glycosylated, and permitted the sequence of the 22 first N-terminal amino acids to be established. This sequence was identical to the predicted protein product of the XK gene cloned recently, which is deleted or mutated in McLeod patients [Ho, M., Chelly, J., Carter, N., Danek, A., Crocker, P. & Monaco, A. P. (1994) Cell 77, 869-880]. Our findings provide strong evidence that the 37-kDa red cell membrane protein is identical to the Kx protein produced by the XK structural gene and demonstrate that Kx and Kell proteins are two subunits expressed as a complex hold by disulfide bond(s) at the red cell surface.

    PMID: 7737196 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read